18575 JAMBOREE ROAD, IRVINE, CA
OnKure Therapeutics Enters $150M Securities Purchase Agreement
Reports Fourth Quarter and Full Year 2025 Financial Results
News, Underwriting Agreement
Financial Results, Press Release
Investor Presentation
News
Reports First Quarter 2025 Financial Results and Business Highlights
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Post-Effective Amendment to Registration Statement